|
|
|
|
| LEADER |
00000cam a2200000Ka 4500 |
| 001 |
11180759 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
130404s2012 nyu o 001 0 eng d |
| 005 |
20240705194127.9 |
| 020 |
|
|
|a 9781620815892
|q (electronic bk.)
|
| 020 |
|
|
|a 1620815893
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)835633581
|
| 035 |
|
9 |
|a (OCLCCM-CC)835633581
|
| 040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d YDXCP
|d E7B
|d OCLCF
|d EBLCP
|d OCLCQ
|d D6H
|d VTS
|d OCLCQ
|d TOF
|d AU@
|d STF
|d OCLCQ
|d K6U
|
| 049 |
|
|
|a MAIN
|
| 050 |
|
4 |
|a R850
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 245 |
0 |
0 |
|a Advances in medicine and biology.
|n Volume 53 /
|c Leon V. Berhardt, editor.
|
| 260 |
|
|
|a New York :
|b Nova Science Publishers,
|c ©2012.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Includes index.
|
| 588 |
0 |
|
|a Title page of PDF version (Ebsco; viewed on April 4, 2013).
|
| 505 |
0 |
|
|a ADVANCES IN MEDICINE AND BIOLOGY ; ADVANCES IN MEDICINE AND BIOLOGY ; Contents ; Preface ; Mesenchymal Stem Cells and Type 1 Diabetes Mellitus ; Abstract ; Introduction ; MSCs: Definition and Identification ; Regenerative Capacities and Homing Characteristics ; Immunosuppressive Potentials ; Differentiation Potentials of MSCs into Surrogate <U+00dd>-Cells ; Genetic Manipulation ; MSCs Plus Islet Cell Transplantation ; Pancreatic MSCs; Diabetic MSCs ; Umbilical Cord Blood MSCs (UCB-MSCs) ; Wharton's Jelly MSCs (WJ-MSCs) ; MSCs and Complications of Diabetes ; Diabetic Cardiomyopathy (DCM)
|
| 505 |
8 |
|
|a Diabetic Nephropathy Diabetic Retinopathy; Safety Issues ; Clinical Trials ; Controversies ; Conclusion ; References; Falls in Elderly Patients ; Abstract ; Introduction; Definition and Dimension of the Problem ; Etiology and Factors Predisposing to Falls ; Consequences of the Falls ; Diagnosis of Risk for Falls (Fall Risk-Prediction Tools) ; Assessing for Risks of Anticipated Physiological Falling ; 2. Strategies to Prevent Unanticipated Physiological and Accidental Falls ; Fall Prevention Strategies; Intervention Plans; Conclusion ; Acknowledgment ; References.
|
| 505 |
8 |
|
|a Recent Advances in Scleroderma Pulmonary FibrosisAbstract ; 1. Introduction; 2. SSc-Associated Interstitial Lung Disease vs. SSc-Associated Pulmonary Arterial Hypertension ; 3. Lung Injury: Repair, Remodeling, and Regeneration ; a) The Inflammatory Phase ; b) The Proliferative Phase ; c) The Remodeling Phase ; 4. Mouse Models and What They Tell Us about SSc-Mediated Interstitial Lung Disease ; 5. Animal Models of SSc Vasculopathy ; a) Fos-Related Antigen-2 (FRA-2) Transgenic Mouse Model ; b) Friend Leukemia Integration Factor-1 (Fli-1) Conditional Knockout Mimics SSc Vasculopathy.
|
| 505 |
8 |
|
|a C) Endothelin-1 (ET-1) Gene and the Tsk/+ Mouse 6. Animal Models of SSc Pulmonary Fibrosis ; a) Peroxisome Proliferator-Activated Receptor-Gamma (PPAR<U+00de>) ; b) Alpha-Melanocyte Stimulating Hormone (<U+0041>-MSH) ; c) Early Growth Response Gene (Egr-1) ; d) The Interactions between Macrophage Chemoattractant Protein-1, Basic Fibroblast Growth Factor, and Connective Tissue Growth Factor to Establish Persistent Fibrosis; 7. The Inflammasomes ; a) Caspase-1; b) IL-1<U+00dd> and IL-18 ; c) IL-1<U+00dd> And IL-18 are Known to Induce Fibrosis ; d) NLRP3 Inflammasome and Pulmonary Fibrosis.
|
| 505 |
8 |
|
|a 8. NLRP3 Inflammasome-Mediated Fibrosis in Other Tissues 9. Novel Inhibitors of Fibrosis ; Conclusion ; References ; Major Histocompatibility Complex: Biology, Functions and Roles in Disease ; Abstract ; Introduction; Evolution of MHC Molecules ; Comparative Genomic Analysis of MHC Region across Primates ; Comparative Genomic Analysis of Mammalian and Non-Mammalian Vertebrate MHC Region ; How the MHC Genes Emerged in Vertebrates ; Evolutionary Forces Maintaining Polymorphism at the MHC Loci ; Biology of MHC Class I Molecules ; Biology of MHC Class II Molecules.
|
| 650 |
|
0 |
|a Clinical medicine.
|0 http://id.loc.gov/authorities/subjects/sh85083129
|
| 650 |
|
0 |
|a Biology
|x Research.
|0 http://id.loc.gov/authorities/subjects/sh89006496
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Biology
|x Research.
|2 fast
|0 (OCoLC)fst00832448
|
| 650 |
|
7 |
|a Clinical medicine.
|2 fast
|0 (OCoLC)fst00864361
|
| 655 |
|
0 |
|a Electronic books.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Berhardt, Leon V.
|0 http://id.loc.gov/authorities/names/n2009185022
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a oclccm
|
| 999 |
f |
f |
|i e13e2aa0-f9c5-569d-9b1c-d00748eb6fdf
|s 6aaad2cb-301e-5950-90fa-f6d02f4b9e00
|
| 928 |
|
|
|t Library of Congress classification
|a R850
|l Online
|c UC-FullText
|u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=535093
|z eBooks on EBSCOhost
|g ebooks
|i 12386879
|
